There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > 2019-nCoV proteins > Spike protein > EP-105

SARS-CoV-2 (COVID-19) Inhibitor screening Kit

For research use only.
Materials Provided
A010-214SARS-CoV-2 Spike RBD10 μg60 μg
A011-214Biotinylated Human ACE210 μg10 μg
A003-214Streptavidin-HRP10 μg10 μg
AC2-NA005SARS-CoV-2 Inhibitor (Human ACE2)20 μg50 μg
  • Background
    The newly identified 2019 novel coronavirus (SARS-CoV-2) has posed a serious threat to human health. Currently, there is no specific treatment for COVID-19. It is urgent to develop the SARS-CoV-2 inhibitors, for example vaccines and therapeutic antibodies and small molecular compounds against COVID-19.
  • Application
    This kit is useful for screening inhibitors of SARS-CoV-2.
    ELISA Buffer Set-96T (EBS-001) is sold separately and not included in kit, and please contact us if you need the buffer.
  • Reconstitution
    See Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage

    Upon receipt, please store all items at -20℃ to -70℃. After reconstitution, the stock solution should be kept at -70℃.

    It is recommended not to freeze thaw more than 3 times.

    This product is stable after storage at: Room temperature (RT) for 1 month in lyophilized state; ●-20℃ to -70℃ for 1 year in lyophilized state; ● -70℃ for 6 months under sterile conditions after reconstitution
  • Assay Principles
    This inhibitor screening ELISA pair is designed to facilitate the identification and characterization of SARS-CoV-2 inhibitors. This assay employs a simple colorimetric ELISA platform, which measures the binding between immobilized SARS-CoV-2 S protein RBD and in-house developed biotinylated Human ACE2 protein. This product is uniquely suitable for rapid high-throughput screening of SARS-CoV-2 inhibitors. Briefly, we provide you with a biotinylated Human ACE2 protein, a SARS-CoV-2 S protein RBD protein, an SARS-CoV-2 inhibitor (as method verified Reference), and Streptavidin-HRP reagent.

    Your experiment will include 4 simple steps:

    a) Coat the plate with SARS-CoV-2 S protein RBD.

    b) Add 50ul biotinylated human ACE2 to coated plate.

    c) Add the reference or your molecule of interest.

    d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

    Finally, the ability of your compound to inhibit S protein RBD: ACE2 binding will be determined by comparing OD readings among different experimental groups.

Typical Data
SARS-CoV-2 Inhibitor screening KitSARS-CoV-2 Inhibitor screening Kit (Cat. No. EP-105) ELISA bioactivity

Binding of Biotinylated Human ACE2 To Immobilized SARS-CoV-2 S protein RBD In A Functional ELISA Assay.
Immobilized 2019-CoV-2 S protein RBD at 0.5 μg/mL (100 μL/well) can bind human ACE2-Biotin with a linear range of 0.001- 0.06 μg/mL when detected by Streptavidin-HRP. Background was subtracted from data points before curve fitting.

SARS-CoV-2 Inhibitor screening KitSARS-CoV-2 Inhibitor screening Kit (Cat. No. EP-105) ELISA bioactivity

Inhibition of Human ACE2 [Biotinylated] :SARS-CoV-2 S protein RBD Binding by SARS-CoV-2 inhibitor.
Serial dilutions of SARS-CoV-2 inhibitor (Cat. No. AC2-NA005) (1:2 serial dilutions, from 20 μg/mL to 0.039 μg/mL (180 nM to 0.35 nM)) was added into Biotinylated ACE2: SARS-CoV-2 S protein RBD binding reactions. The assay was performed according to the above described protocol. Background was subtracted from data points prior to log transformation and curve fitting.

Comments (0)

Order Details

Price(USD) : $600.00

Price(USD) : $2150.00

ELISA Buffer is not included in Inhibitor Screening Kit, please order ELISA Buffer Set if you need in your assay.

Price(USD) : $100.00

Promotion & Exhibitions

Drug Development Status

  • Number of Launched Drugs:1 Details
  • Number of Drugs in Clinical Trials:2 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Questions & Comments

This web search service is supported by Google Inc.